MyoD (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "MyoD" in English language version.

refsWebsite

Global rank English rank

64nih.gov

4^th place

40doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

2harvard.edu

18^th place

17^th place

1uniprot.org

5,673^rd place

6,418^th place

doi.org

Davis RL, Weintraub H, Lassar AB (Dec 1987). "Expression of a single transfected cDNA converts fibroblasts to myoblasts". Cell. 51 (6): 987–1000. doi:10.1016/0092-8674(87)90585-X. PMID 3690668. S2CID 37741454.
Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R (Dec 1993). "MyoD or Myf-5 is required for the formation of skeletal muscle". Cell. 75 (7): 1351–1359. doi:10.1016/0092-8674(93)90621-V. PMID 8269513. S2CID 27322641.
Hinits Y, Williams VC, Sweetman D, Donn TM, Ma TP, Moens CB, et al. (Oct 2011). "Defective cranial skeletal development, larval lethality and haploinsufficiency in Myod mutant zebrafish". Dev. Biol. 358 (1): 102–112. doi:10.1016/j.ydbio.2011.07.015. PMC 3360969. PMID 21798255.
Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB (Oct 1988). "MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts". Science. 242 (4877): 405–511. Bibcode:1988Sci...242..405T. doi:10.1126/science.3175662. PMID 3175662.
Fong AP, Tapscott SJ (October 2013). "Skeletal muscle programming and re-programming". Current Opinion in Genetics & Development. 23 (5): 568–573. doi:10.1016/j.gde.2013.05.002. PMC 3775946. PMID 23756045.
Hughes SM, Koishi K, Rudnicki M, Maggs AM (Jan 1997). "MyoD protein is differentially accumulated in fast and slow skeletal muscle fibres and required for normal fibre type balance in rodents". Mech Dev. 61 (1–2): 151–163. doi:10.1016/S0925-4773(96)00631-4. PMID 9076685. S2CID 17769090.
Ehlers ML, Celona B, Black BL (Sep 2014). "NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity". Cell Reports. 8 (6): 1639–1648. doi:10.1016/j.celrep.2014.08.035. PMC 4180018. PMID 25242327.
Singh K, Cassano M, Planet E, Sebastian S, Jang SM, Sohi G, et al. (Mar 2015). "A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation". Genes & Development. 29 (5): 513–525. doi:10.1101/gad.254532.114. PMC 4358404. PMID 25737281.
Buckingham M, Rigby PW (February 2014). "Gene regulatory networks and transcriptional mechanisms that control myogenesis". Developmental Cell. 28 (3): 225–238. doi:10.1016/j.devcel.2013.12.020. PMID 24525185.
Song YJ, Choi JH, Lee H (Feb 2015). "Setdb1 Is Required for Myogenic Differentiation of C2C12 Myoblast Cells via Maintenance of MyoD Expression". Molecules and Cells. 38 (4): 362–372. doi:10.14348/molcells.2015.2291. PMC 4400312. PMID 25715926.
Rajabi HN, Takahashi C, Ewen ME (Aug 2014). "Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis". The Journal of Biological Chemistry. 289 (34): 23417–23427. doi:10.1074/jbc.M113.532572. PMC 4156083. PMID 25006242.
Milewska M, Grabiec K, Grzelkowska-Kowalczyk K (May 2014). "[Interactions of proliferation and differentiation signaling pathways in myogenesis]". Postepy Higieny I Medycyny Doswiadczalnej. 68: 516–526. doi:10.5604/17322693.1101617 (inactive 23 December 2024). PMID 24864103.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link)
Pan YC, Wang XW, Teng HF, Wu YJ, Chang HC, Chen SL (Feb 2015). "Wnt3a signal pathways activate MyoD expression by targeting cis-elements inside and outside its distal enhancer". Bioscience Reports. 35 (2): 1–12. doi:10.1042/BSR20140177. PMC 4370097. PMID 25651906.
Motohashi N, Asakura A (January 2014). "Muscle satellite cell heterogeneity and self-renewal". Frontiers in Cell and Developmental Biology. 2 (1): 1. doi:10.3389/fcell.2014.00001. PMC 4206996. PMID 25364710.
Micheli L, Leonardi L, Conti F, Buanne P, Canu N, Caruso M, et al. (March 2005). "PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C". Mol. Cell. Biol. 25 (6): 2242–59. doi:10.1128/MCB.25.6.2242-2259.2005. PMC 1061592. PMID 15743821.
Micheli L, Leonardi L, Conti F, Maresca G, Colazingari S, Mattei E, et al. (February 2011). "PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB". J. Biol. Chem. 286 (7): 5691–707. doi:10.1074/jbc.M110.162842. PMC 3037682. PMID 21127072.
Ehlers ML, Celona B, Black BL (Sep 2014). "NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity". Cell Reports. 8 (6): 1639–1648. doi:10.1016/j.celrep.2014.08.035. PMC 4180018. PMID 25242327.
Sartorelli V, Huang J, Hamamori Y, Kedes L (February 1997). "Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C". Molecular and Cellular Biology. 17 (2): 1010–1026. doi:10.1128/mcb.17.2.1010. PMC 231826. PMID 9001254.
Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, et al. (February 1992). "Functional antagonism between c-Jun and MyoD proteins: a direct physical association". Cell. 68 (3): 507–19. doi:10.1016/0092-8674(92)90187-h. PMID 1310896. S2CID 44966899.
Polesskaya A, Naguibneva I, Duquet A, Bengal E, Robin P, Harel-Bellan A (August 2001). "Interaction between acetylated MyoD and the bromodomain of CBP and/or p300". Mol. Cell. Biol. 21 (16): 5312–20. doi:10.1128/MCB.21.16.5312-5320.2001. PMC 87255. PMID 11463815.
Sartorelli V, Huang J, Hamamori Y, Kedes L (February 1997). "Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C". Mol. Cell. Biol. 17 (2): 1010–26. doi:10.1128/mcb.17.2.1010. PMC 231826. PMID 9001254.
Kong Y, Flick MJ, Kudla AJ, Konieczny SF (August 1997). "Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD". Mol. Cell. Biol. 17 (8): 4750–60. doi:10.1128/mcb.17.8.4750. PMC 232327. PMID 9234731.
Zhang JM, Zhao X, Wei Q, Paterson BM (December 1999). "Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation". EMBO J. 18 (24): 6983–93. doi:10.1093/emboj/18.24.6983. PMC 1171761. PMID 10601020.
Zhang JM, Wei Q, Zhao X, Paterson BM (February 1999). "Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4". EMBO J. 18 (4): 926–33. doi:10.1093/emboj/18.4.926. PMC 1171185. PMID 10022835.
Reynaud EG, Leibovitch MP, Tintignac LA, Pelpel K, Guillier M, Leibovitch SA (June 2000). "Stabilization of MyoD by direct binding to p57(Kip2)". J. Biol. Chem. 275 (25): 18767–76. doi:10.1074/jbc.M907412199. PMID 10764802.
Lau P, Bailey P, Dowhan DH, Muscat GE (January 1999). "Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD". Nucleic Acids Res. 27 (2): 411–20. doi:10.1093/nar/27.2.411. PMC 148194. PMID 9862959.
Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz RL, Muscat GE, et al. (October 2001). "Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis". Mol. Cell. 8 (4): 885–97. doi:10.1016/s1097-2765(01)00373-2. PMID 11684023.
Mal A, Sturniolo M, Schiltz RL, Ghosh MK, Harter ML (April 2001). "A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program". EMBO J. 20 (7): 1739–53. doi:10.1093/emboj/20.7.1739. PMC 145490. PMID 11285237.
Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, et al. (March 2004). "The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis". Nature. 428 (6980): 328–32. Bibcode:2004Natur.428..328G. doi:10.1038/nature02329. PMID 15029197. S2CID 4427531.
Langlands K, Yin X, Anand G, Prochownik EV (August 1997). "Differential interactions of Id proteins with basic-helix-loop-helix transcription factors". J. Biol. Chem. 272 (32): 19785–93. doi:10.1074/jbc.272.32.19785. PMID 9242638.
Finkel T, Duc J, Fearon ER, Dang CV, Tomaselli GF (January 1993). "Detection and modulation in vivo of helix-loop-helix protein-protein interactions". J. Biol. Chem. 268 (1): 5–8. doi:10.1016/S0021-9258(18)54105-3. PMID 8380166.
Gupta K, Anand G, Yin X, Grove L, Prochownik EV (March 1998). "Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc". Oncogene. 16 (9): 1149–59. doi:10.1038/sj.onc.1201634. PMID 9528857.
McLoughlin P, Ehler E, Carlile G, Licht JD, Schäfer BW (October 2002). "The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein". J. Biol. Chem. 277 (40): 37045–53. doi:10.1074/jbc.M203336200. PMID 12145280.
Ling MT, Chiu YT, Lee TK, Leung SC, Fung MK, Wang X, et al. (September 2008). "Id-1 induces proteasome-dependent degradation of the HBX protein". J. Mol. Biol. 382 (1): 34–43. doi:10.1016/j.jmb.2007.06.020. PMID 18674781.
Chen CM, Kraut N, Groudine M, Weintraub H (September 1996). "I-mf, a novel myogenic repressor, interacts with members of the MyoD family". Cell. 86 (5): 731–41. doi:10.1016/s0092-8674(00)80148-8. PMID 8797820. S2CID 16252710.
Lenormand JL, Benayoun B, Guillier M, Vandromme M, Leibovitch MP, Leibovitch SA (February 1997). "Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins". Mol. Cell. Biol. 17 (2): 584–93. doi:10.1128/mcb.17.2.584. PMC 231783. PMID 9001211.
Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (February 1993). "Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation". Cell. 72 (3): 309–24. doi:10.1016/0092-8674(93)90110-c. PMID 8381715. S2CID 21581966.
Froeschlé A, Alric S, Kitzmann M, Carnac G, Auradé F, Rochette-Egly C, et al. (July 1998). "Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis". Oncogene. 16 (26): 3369–78. doi:10.1038/sj.onc.1201894. PMID 9692544.
Kataoka Y, Matsumura I, Ezoe S, Nakata S, Takigawa E, Sato Y, et al. (November 2003). "Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts". J. Biol. Chem. 278 (45): 44178–87. doi:10.1074/jbc.M304884200. PMID 12947115.
Maleki SJ, Royer CA, Hurlburt BK (June 1997). "MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable". Biochemistry. 36 (22): 6762–7. doi:10.1021/bi970262m. PMID 9184158.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000129152 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000009471 – Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB (Oct 1988). "MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts". Science. 242 (4877): 405–511. Bibcode:1988Sci...242..405T. doi:10.1126/science.3175662. PMID 3175662.
Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, et al. (March 2004). "The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis". Nature. 428 (6980): 328–32. Bibcode:2004Natur.428..328G. doi:10.1038/nature02329. PMID 15029197. S2CID 4427531.

nih.gov

pubmed.ncbi.nlm.nih.gov

Davis RL, Weintraub H, Lassar AB (Dec 1987). "Expression of a single transfected cDNA converts fibroblasts to myoblasts". Cell. 51 (6): 987–1000. doi:10.1016/0092-8674(87)90585-X. PMID 3690668. S2CID 37741454.
Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R (Dec 1993). "MyoD or Myf-5 is required for the formation of skeletal muscle". Cell. 75 (7): 1351–1359. doi:10.1016/0092-8674(93)90621-V. PMID 8269513. S2CID 27322641.
Hinits Y, Williams VC, Sweetman D, Donn TM, Ma TP, Moens CB, et al. (Oct 2011). "Defective cranial skeletal development, larval lethality and haploinsufficiency in Myod mutant zebrafish". Dev. Biol. 358 (1): 102–112. doi:10.1016/j.ydbio.2011.07.015. PMC 3360969. PMID 21798255.
Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB (Oct 1988). "MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts". Science. 242 (4877): 405–511. Bibcode:1988Sci...242..405T. doi:10.1126/science.3175662. PMID 3175662.
Davis RL, Cheng PF, Lassar AB, Thayer M, Tapscott S, Weintraub H (1989). "MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis". Princess Takamatsu Symposia. 20: 267–278. PMID 2562185.
Fong AP, Tapscott SJ (October 2013). "Skeletal muscle programming and re-programming". Current Opinion in Genetics & Development. 23 (5): 568–573. doi:10.1016/j.gde.2013.05.002. PMC 3775946. PMID 23756045.
Hughes SM, Koishi K, Rudnicki M, Maggs AM (Jan 1997). "MyoD protein is differentially accumulated in fast and slow skeletal muscle fibres and required for normal fibre type balance in rodents". Mech Dev. 61 (1–2): 151–163. doi:10.1016/S0925-4773(96)00631-4. PMID 9076685. S2CID 17769090.
Ehlers ML, Celona B, Black BL (Sep 2014). "NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity". Cell Reports. 8 (6): 1639–1648. doi:10.1016/j.celrep.2014.08.035. PMC 4180018. PMID 25242327.
Singh K, Cassano M, Planet E, Sebastian S, Jang SM, Sohi G, et al. (Mar 2015). "A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation". Genes & Development. 29 (5): 513–525. doi:10.1101/gad.254532.114. PMC 4358404. PMID 25737281.
Buckingham M, Rigby PW (February 2014). "Gene regulatory networks and transcriptional mechanisms that control myogenesis". Developmental Cell. 28 (3): 225–238. doi:10.1016/j.devcel.2013.12.020. PMID 24525185.
Song YJ, Choi JH, Lee H (Feb 2015). "Setdb1 Is Required for Myogenic Differentiation of C2C12 Myoblast Cells via Maintenance of MyoD Expression". Molecules and Cells. 38 (4): 362–372. doi:10.14348/molcells.2015.2291. PMC 4400312. PMID 25715926.
Rajabi HN, Takahashi C, Ewen ME (Aug 2014). "Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis". The Journal of Biological Chemistry. 289 (34): 23417–23427. doi:10.1074/jbc.M113.532572. PMC 4156083. PMID 25006242.
Milewska M, Grabiec K, Grzelkowska-Kowalczyk K (May 2014). "[Interactions of proliferation and differentiation signaling pathways in myogenesis]". Postepy Higieny I Medycyny Doswiadczalnej. 68: 516–526. doi:10.5604/17322693.1101617 (inactive 23 December 2024). PMID 24864103.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link)
Pan YC, Wang XW, Teng HF, Wu YJ, Chang HC, Chen SL (Feb 2015). "Wnt3a signal pathways activate MyoD expression by targeting cis-elements inside and outside its distal enhancer". Bioscience Reports. 35 (2): 1–12. doi:10.1042/BSR20140177. PMC 4370097. PMID 25651906.
Motohashi N, Asakura A (January 2014). "Muscle satellite cell heterogeneity and self-renewal". Frontiers in Cell and Developmental Biology. 2 (1): 1. doi:10.3389/fcell.2014.00001. PMC 4206996. PMID 25364710.
Micheli L, Leonardi L, Conti F, Buanne P, Canu N, Caruso M, et al. (March 2005). "PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C". Mol. Cell. Biol. 25 (6): 2242–59. doi:10.1128/MCB.25.6.2242-2259.2005. PMC 1061592. PMID 15743821.
Micheli L, Leonardi L, Conti F, Maresca G, Colazingari S, Mattei E, et al. (February 2011). "PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB". J. Biol. Chem. 286 (7): 5691–707. doi:10.1074/jbc.M110.162842. PMC 3037682. PMID 21127072.
Ehlers ML, Celona B, Black BL (Sep 2014). "NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity". Cell Reports. 8 (6): 1639–1648. doi:10.1016/j.celrep.2014.08.035. PMC 4180018. PMID 25242327.
Sartorelli V, Huang J, Hamamori Y, Kedes L (February 1997). "Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C". Molecular and Cellular Biology. 17 (2): 1010–1026. doi:10.1128/mcb.17.2.1010. PMC 231826. PMID 9001254.
Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, et al. (February 1992). "Functional antagonism between c-Jun and MyoD proteins: a direct physical association". Cell. 68 (3): 507–19. doi:10.1016/0092-8674(92)90187-h. PMID 1310896. S2CID 44966899.
Polesskaya A, Naguibneva I, Duquet A, Bengal E, Robin P, Harel-Bellan A (August 2001). "Interaction between acetylated MyoD and the bromodomain of CBP and/or p300". Mol. Cell. Biol. 21 (16): 5312–20. doi:10.1128/MCB.21.16.5312-5320.2001. PMC 87255. PMID 11463815.
Sartorelli V, Huang J, Hamamori Y, Kedes L (February 1997). "Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C". Mol. Cell. Biol. 17 (2): 1010–26. doi:10.1128/mcb.17.2.1010. PMC 231826. PMID 9001254.
Kong Y, Flick MJ, Kudla AJ, Konieczny SF (August 1997). "Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD". Mol. Cell. Biol. 17 (8): 4750–60. doi:10.1128/mcb.17.8.4750. PMC 232327. PMID 9234731.
Zhang JM, Zhao X, Wei Q, Paterson BM (December 1999). "Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation". EMBO J. 18 (24): 6983–93. doi:10.1093/emboj/18.24.6983. PMC 1171761. PMID 10601020.
Zhang JM, Wei Q, Zhao X, Paterson BM (February 1999). "Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4". EMBO J. 18 (4): 926–33. doi:10.1093/emboj/18.4.926. PMC 1171185. PMID 10022835.
Reynaud EG, Leibovitch MP, Tintignac LA, Pelpel K, Guillier M, Leibovitch SA (June 2000). "Stabilization of MyoD by direct binding to p57(Kip2)". J. Biol. Chem. 275 (25): 18767–76. doi:10.1074/jbc.M907412199. PMID 10764802.
Lau P, Bailey P, Dowhan DH, Muscat GE (January 1999). "Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD". Nucleic Acids Res. 27 (2): 411–20. doi:10.1093/nar/27.2.411. PMC 148194. PMID 9862959.
Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz RL, Muscat GE, et al. (October 2001). "Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis". Mol. Cell. 8 (4): 885–97. doi:10.1016/s1097-2765(01)00373-2. PMID 11684023.
Mal A, Sturniolo M, Schiltz RL, Ghosh MK, Harter ML (April 2001). "A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program". EMBO J. 20 (7): 1739–53. doi:10.1093/emboj/20.7.1739. PMC 145490. PMID 11285237.
Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, et al. (March 2004). "The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis". Nature. 428 (6980): 328–32. Bibcode:2004Natur.428..328G. doi:10.1038/nature02329. PMID 15029197. S2CID 4427531.
Langlands K, Yin X, Anand G, Prochownik EV (August 1997). "Differential interactions of Id proteins with basic-helix-loop-helix transcription factors". J. Biol. Chem. 272 (32): 19785–93. doi:10.1074/jbc.272.32.19785. PMID 9242638.
Finkel T, Duc J, Fearon ER, Dang CV, Tomaselli GF (January 1993). "Detection and modulation in vivo of helix-loop-helix protein-protein interactions". J. Biol. Chem. 268 (1): 5–8. doi:10.1016/S0021-9258(18)54105-3. PMID 8380166.
Gupta K, Anand G, Yin X, Grove L, Prochownik EV (March 1998). "Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc". Oncogene. 16 (9): 1149–59. doi:10.1038/sj.onc.1201634. PMID 9528857.
McLoughlin P, Ehler E, Carlile G, Licht JD, Schäfer BW (October 2002). "The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein". J. Biol. Chem. 277 (40): 37045–53. doi:10.1074/jbc.M203336200. PMID 12145280.
Ling MT, Chiu YT, Lee TK, Leung SC, Fung MK, Wang X, et al. (September 2008). "Id-1 induces proteasome-dependent degradation of the HBX protein". J. Mol. Biol. 382 (1): 34–43. doi:10.1016/j.jmb.2007.06.020. PMID 18674781.
Chen CM, Kraut N, Groudine M, Weintraub H (September 1996). "I-mf, a novel myogenic repressor, interacts with members of the MyoD family". Cell. 86 (5): 731–41. doi:10.1016/s0092-8674(00)80148-8. PMID 8797820. S2CID 16252710.
Lenormand JL, Benayoun B, Guillier M, Vandromme M, Leibovitch MP, Leibovitch SA (February 1997). "Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins". Mol. Cell. Biol. 17 (2): 584–93. doi:10.1128/mcb.17.2.584. PMC 231783. PMID 9001211.
Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (February 1993). "Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation". Cell. 72 (3): 309–24. doi:10.1016/0092-8674(93)90110-c. PMID 8381715. S2CID 21581966.
Froeschlé A, Alric S, Kitzmann M, Carnac G, Auradé F, Rochette-Egly C, et al. (July 1998). "Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis". Oncogene. 16 (26): 3369–78. doi:10.1038/sj.onc.1201894. PMID 9692544.
Kataoka Y, Matsumura I, Ezoe S, Nakata S, Takigawa E, Sato Y, et al. (November 2003). "Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts". J. Biol. Chem. 278 (45): 44178–87. doi:10.1074/jbc.M304884200. PMID 12947115.
Maleki SJ, Royer CA, Hurlburt BK (June 1997). "MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable". Biochemistry. 36 (22): 6762–7. doi:10.1021/bi970262m. PMID 9184158.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: MYOD1 myogenic differentiation 1".
Hinits Y, Williams VC, Sweetman D, Donn TM, Ma TP, Moens CB, et al. (Oct 2011). "Defective cranial skeletal development, larval lethality and haploinsufficiency in Myod mutant zebrafish". Dev. Biol. 358 (1): 102–112. doi:10.1016/j.ydbio.2011.07.015. PMC 3360969. PMID 21798255.
Fong AP, Tapscott SJ (October 2013). "Skeletal muscle programming and re-programming". Current Opinion in Genetics & Development. 23 (5): 568–573. doi:10.1016/j.gde.2013.05.002. PMC 3775946. PMID 23756045.
Ehlers ML, Celona B, Black BL (Sep 2014). "NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity". Cell Reports. 8 (6): 1639–1648. doi:10.1016/j.celrep.2014.08.035. PMC 4180018. PMID 25242327.
Singh K, Cassano M, Planet E, Sebastian S, Jang SM, Sohi G, et al. (Mar 2015). "A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation". Genes & Development. 29 (5): 513–525. doi:10.1101/gad.254532.114. PMC 4358404. PMID 25737281.
Song YJ, Choi JH, Lee H (Feb 2015). "Setdb1 Is Required for Myogenic Differentiation of C2C12 Myoblast Cells via Maintenance of MyoD Expression". Molecules and Cells. 38 (4): 362–372. doi:10.14348/molcells.2015.2291. PMC 4400312. PMID 25715926.
Rajabi HN, Takahashi C, Ewen ME (Aug 2014). "Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis". The Journal of Biological Chemistry. 289 (34): 23417–23427. doi:10.1074/jbc.M113.532572. PMC 4156083. PMID 25006242.
Pan YC, Wang XW, Teng HF, Wu YJ, Chang HC, Chen SL (Feb 2015). "Wnt3a signal pathways activate MyoD expression by targeting cis-elements inside and outside its distal enhancer". Bioscience Reports. 35 (2): 1–12. doi:10.1042/BSR20140177. PMC 4370097. PMID 25651906.
Motohashi N, Asakura A (January 2014). "Muscle satellite cell heterogeneity and self-renewal". Frontiers in Cell and Developmental Biology. 2 (1): 1. doi:10.3389/fcell.2014.00001. PMC 4206996. PMID 25364710.
Micheli L, Leonardi L, Conti F, Buanne P, Canu N, Caruso M, et al. (March 2005). "PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C". Mol. Cell. Biol. 25 (6): 2242–59. doi:10.1128/MCB.25.6.2242-2259.2005. PMC 1061592. PMID 15743821.
Micheli L, Leonardi L, Conti F, Maresca G, Colazingari S, Mattei E, et al. (February 2011). "PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB". J. Biol. Chem. 286 (7): 5691–707. doi:10.1074/jbc.M110.162842. PMC 3037682. PMID 21127072.
Ehlers ML, Celona B, Black BL (Sep 2014). "NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity". Cell Reports. 8 (6): 1639–1648. doi:10.1016/j.celrep.2014.08.035. PMC 4180018. PMID 25242327.
Sartorelli V, Huang J, Hamamori Y, Kedes L (February 1997). "Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C". Molecular and Cellular Biology. 17 (2): 1010–1026. doi:10.1128/mcb.17.2.1010. PMC 231826. PMID 9001254.
Polesskaya A, Naguibneva I, Duquet A, Bengal E, Robin P, Harel-Bellan A (August 2001). "Interaction between acetylated MyoD and the bromodomain of CBP and/or p300". Mol. Cell. Biol. 21 (16): 5312–20. doi:10.1128/MCB.21.16.5312-5320.2001. PMC 87255. PMID 11463815.
Sartorelli V, Huang J, Hamamori Y, Kedes L (February 1997). "Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C". Mol. Cell. Biol. 17 (2): 1010–26. doi:10.1128/mcb.17.2.1010. PMC 231826. PMID 9001254.
Kong Y, Flick MJ, Kudla AJ, Konieczny SF (August 1997). "Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD". Mol. Cell. Biol. 17 (8): 4750–60. doi:10.1128/mcb.17.8.4750. PMC 232327. PMID 9234731.
Zhang JM, Zhao X, Wei Q, Paterson BM (December 1999). "Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation". EMBO J. 18 (24): 6983–93. doi:10.1093/emboj/18.24.6983. PMC 1171761. PMID 10601020.
Zhang JM, Wei Q, Zhao X, Paterson BM (February 1999). "Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4". EMBO J. 18 (4): 926–33. doi:10.1093/emboj/18.4.926. PMC 1171185. PMID 10022835.
Lau P, Bailey P, Dowhan DH, Muscat GE (January 1999). "Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD". Nucleic Acids Res. 27 (2): 411–20. doi:10.1093/nar/27.2.411. PMC 148194. PMID 9862959.
Mal A, Sturniolo M, Schiltz RL, Ghosh MK, Harter ML (April 2001). "A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program". EMBO J. 20 (7): 1739–53. doi:10.1093/emboj/20.7.1739. PMC 145490. PMID 11285237.
Lenormand JL, Benayoun B, Guillier M, Vandromme M, Leibovitch MP, Leibovitch SA (February 1997). "Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins". Mol. Cell. Biol. 17 (2): 584–93. doi:10.1128/mcb.17.2.584. PMC 231783. PMID 9001211.

semanticscholar.org

api.semanticscholar.org

Davis RL, Weintraub H, Lassar AB (Dec 1987). "Expression of a single transfected cDNA converts fibroblasts to myoblasts". Cell. 51 (6): 987–1000. doi:10.1016/0092-8674(87)90585-X. PMID 3690668. S2CID 37741454.
Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R (Dec 1993). "MyoD or Myf-5 is required for the formation of skeletal muscle". Cell. 75 (7): 1351–1359. doi:10.1016/0092-8674(93)90621-V. PMID 8269513. S2CID 27322641.
Hughes SM, Koishi K, Rudnicki M, Maggs AM (Jan 1997). "MyoD protein is differentially accumulated in fast and slow skeletal muscle fibres and required for normal fibre type balance in rodents". Mech Dev. 61 (1–2): 151–163. doi:10.1016/S0925-4773(96)00631-4. PMID 9076685. S2CID 17769090.
Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, et al. (February 1992). "Functional antagonism between c-Jun and MyoD proteins: a direct physical association". Cell. 68 (3): 507–19. doi:10.1016/0092-8674(92)90187-h. PMID 1310896. S2CID 44966899.
Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, et al. (March 2004). "The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis". Nature. 428 (6980): 328–32. Bibcode:2004Natur.428..328G. doi:10.1038/nature02329. PMID 15029197. S2CID 4427531.
Chen CM, Kraut N, Groudine M, Weintraub H (September 1996). "I-mf, a novel myogenic repressor, interacts with members of the MyoD family". Cell. 86 (5): 731–41. doi:10.1016/s0092-8674(00)80148-8. PMID 8797820. S2CID 16252710.
Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (February 1993). "Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation". Cell. 72 (3): 309–24. doi:10.1016/0092-8674(93)90110-c. PMID 8381715. S2CID 21581966.

uniprot.org

"P15172 (MYOD1_HUMAN)". UniProtKB. Retrieved 17 July 2019.